Proxy Votes Now

Home › Funds › T. Rowe Price › T. Rowe Price Extended Equity Market Index Fund

T. Rowe Price Extended Equity Market Index Fund (PEXMX) proxy voting record 2025-2026

Fund family: T. Rowe Price · Filed by T. Rowe Price Index Trust, Inc. (CIK 858581) · SEC series S000002090

Ticker: PEXMX (C000005458)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 13,606 with, 102 against, 0 abstentions (not counted as with management); 3 items carried no recommendation. Shareholder proposals: 31 FOR, 66 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with T. Rowe Price as a whole

The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsT. Rowe PriceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)88.5%13,25593.7%208,710
Backed environmental and social shareholder proposals at US companiesn/a232.6%3,333

Where this fund voted differently from most T. Rowe Price funds

Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most T. Rowe Price funds on 120 items (1.9% of the 6,231 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Avalo Therapeutics, Inc.2026-06-02To approve the Avalo Therapeutics, Inc. Second Amended and Restated 2016 Employee Stock Purchase Plan;AgainstFOR — 8 of 8 T. Rowe Price fundsAgainst—
Immunovant, Inc.2025-08-27To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Douglas HughesWithholdFOR — 8 of 9 T. Rowe Price fundsAgainstElected, 89.5% support
Goosehead Insurance, Inc.2026-05-04Election of Directors: Robyn JonesForWITHHOLD — 7 of 8 T. Rowe Price fundsForElected, 77.3% support
Goosehead Insurance, Inc.2026-05-04Election of Directors: William Wade, Jr.ForWITHHOLD — 7 of 8 T. Rowe Price fundsForElected, 77.3% support
Middlesex Water Company2026-05-19Election of Directors: Vaughn L. McKoyForWITHHOLD — 7 of 8 T. Rowe Price fundsForPassed (calculated), 79.7% support
Vishay Precision Group, Inc.2026-05-19Election of Directors: Nava Swersky SoferForWITHHOLD — 7 of 8 T. Rowe Price fundsFor—
Vishay Precision Group, Inc.2026-05-19Election of Directors: Saul ReibsteinForWITHHOLD — 7 of 8 T. Rowe Price fundsFor—
Vishay Precision Group, Inc.2026-05-19Election of Directors: Sejal Shah GulatiForWITHHOLD — 7 of 8 T. Rowe Price fundsFor—
Texas Capital Bancshares, Inc.2026-04-21To elect ten (10) directors - each to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Thomas E. LongForWITHHOLD — 7 of 8 T. Rowe Price fundsForElected, 85.7% support
TWFG, Inc.2026-05-27Elect each of the six director nominees for a one-year term: Janet S. WongWithholdFOR — 7 of 8 T. Rowe Price fundsAgainst—
TWFG, Inc.2026-05-27Elect each of the six director nominees for a one-year term: Jonathan AndersonWithholdFOR — 7 of 8 T. Rowe Price fundsAgainst—
TWFG, Inc.2026-05-27Elect each of the six director nominees for a one-year term: Michael DoakWithholdFOR — 7 of 8 T. Rowe Price fundsAgainst—
TWFG, Inc.2026-05-27Elect each of the six director nominees for a one-year term: Robin A. FerraconeWithholdFOR — 7 of 8 T. Rowe Price fundsAgainst—
Loar Holdings Inc.2026-06-023 wordings Election of Raja Bobbili, Alison Bomberg and Margaret (Peg) McGetrick as Class II directors, each to hold office until our annual meeting of stockholders in 2029 and until their successor is duly elected and qualified, or until their earlier death, resignation, or removal: Raja BobbiliWithholdFOR — 9 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.6% support
UL Solutions Inc.2026-05-20Election of Directors: Elisabeth TorstadWithholdFOR — 10 of 13 T. Rowe Price fundsAgainst—
UL Solutions Inc.2026-05-20Election of Directors: George A. WilliamsWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.7% support
UL Solutions Inc.2026-05-20Election of Directors: James M. ShannonWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.8% support
UL Solutions Inc.2026-05-20Election of Directors: James P. DolliveWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.6% support
UL Solutions Inc.2026-05-20Election of Directors: Marla C. GottschalkWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.8% support
UL Solutions Inc.2026-05-20Election of Directors: Sally SusmanWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.9% support
GPGI, Inc.2026-06-11Election of Directors: Brian F. HughesWithholdFOR — 6 of 7 T. Rowe Price fundsAgainstPassed (calculated), 97.8% support
GPGI, Inc.2026-06-11Election of Directors: Joseph J. DeAngeloWithholdFOR — 6 of 7 T. Rowe Price fundsAgainstPassed (calculated), 99.8% support
GPGI, Inc.2026-06-11Election of Directors: Mark R. JamesWithholdFOR — 6 of 7 T. Rowe Price fundsAgainstPassed (calculated), 92.2% support
OceanFirst Financial Corp.2026-04-02A proposal to approve the issuance of (a) OceanFirst common stock to holders of Flushing common stock (the "Flushing stockholders") pursuant to the merger agreement and (b) OceanFirst common stock, a new class of non-voting, common-equivalent stock of OceanFirst ("OceanFirst NVCE stock") and a warraForAGAINST — 6 of 7 T. Rowe Price fundsForApproved, 94.3% support
Kearny Financial Corp.2025-10-21The election of the five nominees listed, for the term indicated: Christopher Petermann, three-year termForWITHHOLD — 6 of 7 T. Rowe Price fundsForPassed (calculated), 88.4% support
Show all 120
Items 26 to 120.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Kearny Financial Corp.2025-10-21The election of the five nominees listed, for the term indicated: John F. McGovern, three-year termForWITHHOLD — 6 of 7 T. Rowe Price fundsForPassed (calculated), 86.2% support
Kearny Financial Corp.2025-10-21The election of the five nominees listed, for the term indicated: John J. Mazur, Jr., three-year termForWITHHOLD — 6 of 7 T. Rowe Price fundsForPassed (calculated), 82.9% support
Cytokinetics, Incorporated2026-05-272 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D.WithholdFOR — 15 of 22 T. Rowe Price fundsAgainstPassed (calculated), 97.0% support
Noble Corporation plc2026-04-29Authorization of the Board to Allot Shares without Rights of Pre-Emption.AgainstFOR — 7 of 9 T. Rowe Price fundsAgainstApproved, 81.0% support
Noble Corporation plc2026-04-29Authorization of the Board to Allot Shares.AgainstFOR — 7 of 9 T. Rowe Price fundsAgainst—
Adaptive Biotechnologies Corporation2026-06-05To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders: Robert Hershberg, PhD, MDForWITHHOLD — 7 of 9 T. Rowe Price fundsFor—
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Jody A. MarkopoulosWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: John W. KuoWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Kenneth C. BockhorstWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Lawrence D. KingsleyWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Robert A. CascellaWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Sheila RegeWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Steven W. EtzelWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mercury Systems, Inc.2025-10-22To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Howard L. LanceWithholdFOR — 7 of 9 T. Rowe Price fundsAgainst—
Mercury Systems, Inc.2025-10-22To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Lisa S. DisbrowWithholdFOR — 7 of 9 T. Rowe Price fundsAgainst—
Applied Optoelectronics, Inc.2026-06-04Class I Directors for Election: Che-Wei LinForWITHHOLD — 7 of 9 T. Rowe Price fundsFor—
Applied Optoelectronics, Inc.2026-06-04Class I Directors for Election: Robert (Bob) FlanaganForWITHHOLD — 7 of 9 T. Rowe Price fundsFor—
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Blake W. AugsburgerWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 97.4% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Denis G. SuggsWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 93.5% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: John A. ForbesWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 92.6% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Joseph M. CerulliWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 83.6% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: M. Scott WelchWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 93.4% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Michael A. KitsonWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 96.3% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Natalie A. BrownWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 94.3% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Todd M. ClevelandWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 96.5% support
Peloton Interactive, Inc.2025-12-09Election of Directors: Chris BruzzoForWITHHOLD — 7 of 9 T. Rowe Price fundsForElected, 77.8% support
Root, Inc.2026-06-03To elect three Class III directors, Lawrence Hilsheimer, Alexander Timm and Douglas Ulman, each to hold office until our Annual Meeting of Stockholders in 2029: Lawrence HilsheimerForAGAINST — 7 of 9 T. Rowe Price fundsForElected, 92.8% support
Ryan Specialty Holdings, Inc.2026-04-28Election five director nominees: Anthony J. KuczinskiAgainstFOR — 5 of 6 T. Rowe Price fundsAgainst—
Ryan Specialty Holdings, Inc.2026-04-28Election five director nominees: Michael G. BungertAgainstFOR — 5 of 6 T. Rowe Price fundsAgainstElected, 99.8% support
Service Corporation International2026-05-06Election of Directors: Marcus A. WattsForAGAINST — 12 of 18 T. Rowe Price fundsForFailed (calculated), 43.5% support
Service Corporation International2026-05-06To approve the 2026 Equity Incentive Plan.AgainstFOR — 12 of 18 T. Rowe Price fundsAgainstApproved, 78.1% support
CRISPR Therapeutics AG2026-06-04Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainst—
CRISPR Therapeutics AG2026-06-04Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainst—
CRISPR Therapeutics AG2026-06-04Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainst—
CRISPR Therapeutics AG2026-06-04Non-binding advisory vote on the 2025 Compensation Report.AgainstFOR — 5 of 6 T. Rowe Price fundsAgainst—
CRISPR Therapeutics AG2026-06-04Re-election of Ali Behbahani, M.D.ForAGAINST — 5 of 6 T. Rowe Price fundsFor—
CRISPR Therapeutics AG2026-06-04Re-election of the members of the Compensation Committee: Re-election of Ali Behbahani, M.D.ForAGAINST — 5 of 6 T. Rowe Price fundsFor—
BJ's Wholesale Club Holdings, Inc.2026-06-18Shareholder Vote on a shareholder proposal regarding a report on deforestation in the company's own-brand supply chain, if properly presented at the meeting.ForAGAINST — 8 of 11 T. Rowe Price fundsAgainst—
BJ's Wholesale Club Holdings, Inc.2026-06-18Shareholder Vote on a shareholder proposal regarding a report on greenhouse gas emissions reduction efforts, if properly presented at the meeting.ForAGAINST — 8 of 11 T. Rowe Price fundsAgainst—
IonQ, Inc.2026-06-16To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: Kathryn K. ChouWithholdFOR — 6 of 8 T. Rowe Price fundsAgainstElected, 71.3% support
IonQ, Inc.2026-06-16To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: William F. ScannellWithholdFOR — 6 of 8 T. Rowe Price fundsAgainstElected, 83.0% support
Prosperity Bancshares, Inc.2026-04-21Election of four (4) Class I directors to serve on the Board of Directors of the Company until the Company's 2029 annual meeting of shareholders: Harrison Stafford II (Class I)WithholdFOR — 6 of 8 T. Rowe Price fundsAgainstPassed (calculated), 96.3% support
Prosperity Bancshares, Inc.2026-04-21Election of four (4) Class I directors to serve on the Board of Directors of the Company until the Company's 2029 annual meeting of shareholders: Perry Mueller, Jr. (Class I)WithholdFOR — 6 of 8 T. Rowe Price fundsAgainstPassed (calculated), 87.8% support
CRISPR Therapeutics AG2026-06-04Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.AgainstFOR — 6 of 8 T. Rowe Price fundsAgainstApproved, 69.4% support
Kadant Inc.2026-05-20Election of two directors to the class to be elected for a three-year term expiring in 2029: Thomas C. LeonardAgainstFOR — 6 of 8 T. Rowe Price fundsAgainst—
Surgery Partners, Inc.2026-06-05Election of Class II Directors: Brent TurnerWithholdFOR — 6 of 8 T. Rowe Price fundsAgainstElected, 96.9% support
PBF Energy Inc.2026-04-28Election of Directors: Spencer AbrahamAgainstFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 89.4% support
Element Solutions Inc2026-05-04Election of Directors: E. Stanley O'NealForAGAINST — 7 of 10 T. Rowe Price fundsForPassed (calculated), 94.2% support
ESCO Technologies Inc.2026-01-30Election of Directors: Patrick M. DewarWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 96.4% support
ESCO Technologies Inc.2026-01-30Election of Directors: Vinod M. KhilnaniWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 96.6% support
Flagstar Bank, N.A.2026-06-09Election of Directors: Marshall LuxAgainstFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 98.0% support
Ambarella, Inc.2026-06-26Election of Directors: D. Jeffrey RichardsonWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 89.0% support
Ambarella, Inc.2026-06-26Election of Directors: Elizabeth M. SchwartingWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 80.4% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: David Alexander PlouffeWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstPassed (calculated), 99.5% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Siddhartha SankaranWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstPassed (calculated), 99.7% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: William (Bill) J. Gassen IIIWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstPassed (calculated), 96.9% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Abid RizviAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Alissa AhlmanAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Mary BaglivoAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Richard ZanninoAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 95.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Robert FischAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.3% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stanley FleishmanAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 90.7% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stephen WhiteAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.5% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Thomas HendricksonAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.0% support
Element Solutions Inc2026-05-04Advisory vote to approve the Company's 2025 executive compensationAgainstFOR — 8 of 13 T. Rowe Price fundsAgainstFailed (calculated), 41.4% support
Dutch Bros Inc.2026-05-13Election of Directors: Todd PenegorForAGAINST — 10 of 17 T. Rowe Price fundsForElected, 91.7% support
Dutch Bros Inc.2026-05-13Election of Directors: Travis BoersmaForAGAINST — 10 of 17 T. Rowe Price fundsForElected, 95.6% support
Flagstar Bank, N.A.2026-06-09An advisory vote to approve, on a non-binding basis, compensation of our named executive officers disclosed in the accompanying proxy statement.AgainstFOR — 8 of 13 T. Rowe Price fundsAgainstPassed (calculated), 81.2% support
Pinnacle Financial Partners, Inc.2025-11-06A proposal to approve and adopt the Agreement and Plan of Merger by and among Pinnacle Financial Partners, Inc. ("Pinnacle"), Synovus Financial Corp. ("Synovus") and Steel Newco Inc. ("Newco"), dated as of July 24, 2025 (as amended from time to time, the "merger agreement"), pursuant to which, on thForAGAINST — 6 of 9 T. Rowe Price fundsFor—
Clean Harbors, Inc.2026-05-20To elect four (4) Class I members of the Board of Directors of the Company to serve until the 2029 Annual Meeting of Shareholders: John R. WelchWithholdFOR — 6 of 9 T. Rowe Price fundsAgainstPassed (calculated), 98.5% support
Clean Harbors, Inc.2026-05-20To elect four (4) Class I members of the Board of Directors of the Company to serve until the 2029 Annual Meeting of Shareholders: Shelley Stewart, Jr.WithholdFOR — 6 of 9 T. Rowe Price fundsAgainstPassed (calculated), 99.4% support
Advanced Energy Industries, Inc.2026-05-07Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; andAgainstFOR — 6 of 9 T. Rowe Price fundsAgainstApproved, 78.4% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Amin N. MarediaAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Edward N. AntoianAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 97.6% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Harry S. Cherken, Jr.AgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.4% support
Urban Outfitters, Inc.2026-06-03Election of Directors: John C. MullikenAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 97.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Kelly CampbellAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 99.3% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Mary C. EganAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Todd R. MorgenfeldAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 99.1% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Wesley S. McDonaldAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.3% support
Interparfums, Inc.2025-09-10To vote for the advisory resolution to approve executive compensation.AgainstFOR — 7 of 11 T. Rowe Price fundsAgainstApproved, 84.3% support
Marqeta, Inc.2026-06-10To approve an amendment to our Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law.ForAGAINST — 7 of 11 T. Rowe Price fundsForPassed (calculated), 78.7% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Judson (Jud) LiForWITHHOLD — 7 of 11 T. Rowe Price fundsForPassed (calculated), 92.2% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Martha CummingsForWITHHOLD — 7 of 11 T. Rowe Price fundsForPassed (calculated), 82.1% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Najuma AtkinsonForWITHHOLD — 7 of 11 T. Rowe Price fundsForPassed (calculated), 87.8% support
Marqeta, Inc.2026-06-10To approve, on a non-binding advisory basis, the compensation of our named executive officers.ForAGAINST — 8 of 14 T. Rowe Price fundsForPassed (calculated), 78.5% support
Installed Building Products, Inc.2026-05-19Election of Directors to serve for three-year terms: Robert H. SchottensteinAgainstFOR — 7 of 12 T. Rowe Price fundsAgainstElected, 93.9% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: David Schenkein, M.D.ForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 73.5% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: Jennifer CookForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 60.9% support
Impinj, Inc.2026-05-28Election of Directors: Steve SanghiForAGAINST — 7 of 13 T. Rowe Price fundsForElected, 68.1% support
Atlassian Corporation2025-12-02Election of Directors: Christian SmithForAGAINST — 3 of 5 T. Rowe Price fundsForPassed (calculated), 99.8% support
Atlassian Corporation2025-12-02Election of Directors: Richard P. WongForAGAINST — 3 of 5 T. Rowe Price fundsForPassed (calculated), 94.8% support
Atlassian Corporation2025-12-02Election of Directors: Shona L. BrownForAGAINST — 3 of 5 T. Rowe Price fundsForPassed (calculated), 96.3% support
Arrow Electronics, Inc.2026-05-12Shareholder Shareholder proposal to provide shareholders with the ability to call a special shareholder meeting at a 10% ownership threshold.AgainstFOR — 3 of 5 T. Rowe Price fundsFor—
Symbotic Inc.2026-03-05To approve an advisory vote on the compensation paid to our named executive officers.ForAGAINST — 2 of 3 T. Rowe Price fundsForPassed (calculated), 99.0% support

Download all 120 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 96.1% of this fund’s 13,708 such votes could be given a sector; the other 529 (3.9%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary3,031471.6%
Finance2,50180.3%
Industrials1,811140.8%
Technology1,66390.5%
Health Care1,639120.7%
Real Estate86520.2%
Energy53200.0%
Utilities38020.5%
Consumer Staples26562.3%
Miscellaneous20200.0%
Telecommunications15410.6%
Basic Materials13600.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections9,52616
Say-on-Pay1,5950
Audit-related1,4900
Compensation5060
Corporate Governance36354
Extraordinary Transactions1431
Capital Structure1421
Shareholder Rights and Defenses527
Environment or Climate1212
Other Social Issues77

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Sandisk CorporationNovember 18, 2025$17M100
Marvell Technology, Inc.June 25, 2026$17M101
Snowflake Inc.June 29, 2026$13M61
Snowflake Inc.July 2, 2025$13M70
Cloudflare, Inc.June 30, 2026$13M140
Cheniere Energy, Inc.May 14, 2026$9M110
Ferguson Enterprises Inc.December 3, 2025$7M130
Ferguson Enterprises Inc.April 30, 2026$7M130

Notable votes against management

MeetingCompanyProposalFundMgmt
June 25, 2026Marvell Technology, Inc.To consider and act on one stockholder proposal, entitled "Independent Board Chairman", if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
June 29, 2026Snowflake Inc.To consider and vote on, if properly presented at the meeting, a non-binding stockholder proposal requesting majority vote for director elections. Shareholder proposalForAgainst
September 3, 2025Casey's General Stores, Inc.Shareholder proposal regarding Scope 3 greenhouse gas reduction targets. Shareholder proposalAgainstFor
May 6, 2026Entegris, Inc.Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposalAgainstFor
May 20, 2026Markel Group Inc.Shareholder proposal for a report on the Company's strategies and action plans to mitigate material environmental risks. Shareholder proposalAgainstFor
May 20, 2026Markel Group Inc.Shareholder proposal to give shareholders an ability to call for a special shareholder meeting. Shareholder proposalAgainstFor
May 20, 2026Reliance, Inc.To consider a stockholder proposal requiring any director who fails to receive a majority vote to leave the board of directors within nine months. Shareholder proposalAgainstFor
May 4, 2026First Citizens BancShares, Inc.Proposal requesting a report on faith-based employee resource groups. Shareholder proposalAgainstFor
January 12, 2026Zscaler, Inc.To vote on a non-binding stockholder proposal requesting the declassification of our board of directors. Shareholder proposalForAgainst
June 1, 2026DocuSign, Inc.A stockholder proposal to report on the risks of non-fiduciary executive compensation metrics, if properly presented at the meeting Shareholder proposalAgainstFor
May 15, 2026Medpace Holdings, Inc.Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposalAgainstFor
May 11, 2026MKS Inc.A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (10 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

13,840 ballot items at 1,621 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, T. Rowe Price Extended Equity Market Index Fund (PEXMX) voted at 1,621 shareholder meetings of 1,548 companies, on 13,840 ballot items in all. Where management made a recommendation, the fund followed it on 99.3% of the items and voted against it 102 times. Its most frequent area of disagreement was corporate governance (54 of its votes against management). It voted FOR 32.0% of the 97 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (88.5% against 93.7%). It voted differently from most T. Rowe Price funds on 120 items. 10 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.